Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2024 Filed Feb 13, 2024 22:07 UTC |
BOUSBIB ARIDirector · See Remarks
|
Tax withholdingCommon Stock | 3,909 | $218.20 | $852,943.80 |
DisclosureSEC source: 0001478242-24-000026 · wk-form4_1707862037.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 788,918 Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 22:08 UTC |
Bruehlman Ronald ESee Remarks
|
Tax withholdingCommon Stock | 1,033 | $218.20 | $225,400.60 |
DisclosureSEC source: 0001478242-24-000027 · wk-form4_1707862086.xml · nonDerivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,298 Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 22:20 UTC |
Cherofsky KeriannSee Remarks
|
GrantStock Appreciation Right · Derivative | 1,726 | $0.00 Strike: $214.34 | $0.00 |
DisclosureSEC source: 0001478242-24-000018 · wk-form4_1707430792.xml · derivative · entry 1 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,726 Underlying: Common Stock · 1,726 shares Expires 2034-02-07 F1 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 7, 2025. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 22:19 UTC |
STAUB W RICHARDSee Remarks
|
GrantStock Appreciation Right · Derivative | 13,812 | $0.00 Strike: $214.34 | $0.00 |
DisclosureSEC source: 0001478242-24-000017 · wk-form4_1707430756.xml · derivative · entry 3 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,812 Underlying: Common Stock · 13,812 shares Expires 2034-02-07 F2 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 7, 2025. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 22:18 UTC |
Bruehlman Ronald ESee Remarks
|
GrantStock Appreciation Right · Derivative | 20,719 | $0.00 Strike: $214.34 | $0.00 |
DisclosureSEC source: 0001478242-24-000016 · wk-form4_1707430726.xml · derivative · entry 4 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,719 Underlying: Common Stock · 20,719 shares Expires 2034-02-07 F3 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 7, 2025. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 22:18 UTC |
Knightly Kevin CSee Remarks
|
GrantStock Appreciation Right · Derivative | 6,906 | $0.00 Strike: $214.34 | $0.00 |
DisclosureSEC source: 0001478242-24-000015 · wk-form4_1707430689.xml · derivative · entry 3 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,906 Underlying: Common Stock · 6,906 shares Expires 2034-02-07 F2 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 7, 2025. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 22:17 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantStock Appreciation Right · Derivative | 72,517 | $0.00 Strike: $214.34 | $0.00 |
DisclosureSEC source: 0001478242-24-000014 · wk-form4_1707430648.xml · derivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,517 Underlying: Common Stock · 72,517 shares Expires 2034-02-07 F3 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 7, 2025. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 22:17 UTC |
Sherbet EricSee Remarks
|
GrantStock Appreciation Right · Derivative | 9,496 | $0.00 Strike: $214.34 | $0.00 |
DisclosureSEC source: 0001478242-24-000013 · wk-form4_1707430610.xml · derivative · entry 3 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,496 Underlying: Common Stock · 9,496 shares Expires 2034-02-07 F2 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 7, 2025. Read SEC document |
| February 07, 2024 Filed May 9, 2024 21:07 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 140 | $214.34 | $30,007.60 |
DisclosureSEC source: 0001478242-24-000081 · wk-form4_1715288845.xml · derivative · entry 2 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,723 Underlying: Common Stock · 140 shares Expires not disclosed F3 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F3 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F3 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 07, 2024 Filed May 9, 2024 21:09 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 163 | $214.34 | $34,937.42 |
DisclosureSEC source: 0001478242-24-000084 · wk-form4_1715288965.xml · derivative · entry 2 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,481 Underlying: Common Stock · 163 shares Expires not disclosed F2 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F2 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F2 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 07, 2024 Filed May 9, 2024 21:09 UTC |
Fasano JimDirector
|
GrantDeferred Shares · Derivative | 163 | $214.34 | $34,937.42 |
DisclosureSEC source: 0001478242-24-000083 · wk-form4_1715288930.xml · derivative · entry 1 Fasano Jim · CIK 0001633043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163 Underlying: Common Stock · 163 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 07, 2024 Filed May 9, 2024 21:08 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 128 | $214.34 | $27,435.52 |
DisclosureSEC source: 0001478242-24-000082 · wk-form4_1715288887.xml · derivative · entry 1 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,133 Underlying: Common Stock · 128 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 22:19 UTC |
STAUB W RICHARDSee Remarks
|
Tax withholdingCommon Stock | 3,148 | $215.41 | $678,110.68 |
DisclosureSEC source: 0001478242-24-000017 · wk-form4_1707430756.xml · nonDerivative · entry 2 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,613 Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 22:19 UTC |
STAUB W RICHARDSee Remarks
|
GrantCommon Stock | 8,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-24-000017 · wk-form4_1707430756.xml · nonDerivative · entry 1 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,761 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 9, 2021. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 6, 2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 22:18 UTC |
Bruehlman Ronald ESee Remarks
|
Tax withholdingCommon Stock | 10,514 | $215.41 | $2,264,820.74 |
DisclosureSEC source: 0001478242-24-000016 · wk-form4_1707430726.xml · nonDerivative · entry 2 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,331 Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 22:18 UTC |
Bruehlman Ronald ESee Remarks
|
GrantCommon Stock | 24,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-24-000016 · wk-form4_1707430726.xml · nonDerivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,845 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 9, 2021. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 6, 2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 22:18 UTC |
Knightly Kevin CSee Remarks
|
Tax withholdingCommon Stock | 2,688 | $215.41 | $579,022.08 |
DisclosureSEC source: 0001478242-24-000015 · wk-form4_1707430689.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,526 Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 22:18 UTC |
Knightly Kevin CSee Remarks
|
GrantCommon Stock | 7,241 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-24-000015 · wk-form4_1707430689.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,214 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 9, 2021. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 6, 2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 22:17 UTC |
BOUSBIB ARIDirector · See Remarks
|
Tax withholdingCommon Stock | 43,677 | $215.41 | $9,408,462.57 |
DisclosureSEC source: 0001478242-24-000014 · wk-form4_1707430648.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 792,827 Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 22:17 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantCommon Stock | 86,912 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-24-000014 · wk-form4_1707430648.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 836,504 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 9, 2021. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 6, 2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 22:17 UTC |
Sherbet EricSee Remarks
|
Tax withholdingCommon Stock | 2,372 | $215.41 | $510,952.52 |
DisclosureSEC source: 0001478242-24-000013 · wk-form4_1707430610.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,406 Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 22:17 UTC |
Sherbet EricSee Remarks
|
GrantCommon Stock | 7,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-24-000013 · wk-form4_1707430610.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,778 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 9, 2021. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 6, 2024. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:01 UTC |
Knightly Kevin CSee Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 10,207 | $59.90 Strike: $59.90 | $611,399.30 |
DisclosureSEC source: 0001478242-23-000103 · wk-form4_1701813671.xml · derivative · entry 8 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,207 shares Expires 2026-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:01 UTC |
Knightly Kevin CSee Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 8,284 | $65.16 Strike: $65.16 | $539,785.44 |
DisclosureSEC source: 0001478242-23-000103 · wk-form4_1701813671.xml · derivative · entry 7 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,284 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:01 UTC |
Knightly Kevin CSee Remarks
|
Disposition to issuerCommon Stock | 5,374 | $214.23 | $1,151,272.02 |
DisclosureSEC source: 0001478242-23-000103 · wk-form4_1701813671.xml · nonDerivative · entry 6 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,973 Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:01 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 378 | $215.29 | $81,379.62 |
DisclosureSEC source: 0001478242-23-000103 · wk-form4_1701813671.xml · nonDerivative · entry 5 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,347 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $215.14 to $215.53, inclusive. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:01 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 5,855 | $214.32 | $1,254,843.60 |
DisclosureSEC source: 0001478242-23-000103 · wk-form4_1701813671.xml · nonDerivative · entry 4 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,725 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $214.08 to $215.06, inclusive. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:01 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 6,884 | $213.72 | $1,471,248.48 |
DisclosureSEC source: 0001478242-23-000103 · wk-form4_1701813671.xml · nonDerivative · entry 3 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,580 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $213.08 to $214.07 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:01 UTC |
Knightly Kevin CSee Remarks
|
Exercise / conversionCommon Stock | 10,207 | $59.90 | $611,399.30 |
DisclosureSEC source: 0001478242-23-000103 · wk-form4_1701813671.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:01 UTC |
Knightly Kevin CSee Remarks
|
Exercise / conversionCommon Stock | 8,284 | $65.16 | $539,785.44 |
DisclosureSEC source: 0001478242-23-000103 · wk-form4_1701813671.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2023 Filed Feb 8, 2024 22:14 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 156 | $191.91 | $29,937.96 |
DisclosureSEC source: 0001478242-24-000011 · wk-form5_1707430480.xml · derivative · entry 4 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,583 Underlying: Common Stock · 156 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| November 09, 2023 Filed Feb 8, 2024 22:15 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 143 | $191.91 | $27,443.13 |
DisclosureSEC source: 0001478242-24-000012 · wk-form5_1707430544.xml · derivative · entry 4 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,005 Underlying: Common Stock · 143 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| November 09, 2023 Filed Feb 8, 2024 22:13 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 182 | $191.91 | $34,927.62 |
DisclosureSEC source: 0001478242-24-000010 · wk-form5_1707430384.xml · derivative · entry 4 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,318 Underlying: Common Stock · 182 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| September 19, 2023 Filed Sep 21, 2023 17:01 UTC |
Panagos ConstantinosSee Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 4,450 | $0.00 Strike: $183.82 | $0.00 |
DisclosureSEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · derivative · entry 11 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,225 Underlying: Common Stock · 4,450 shares Expires 2031-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2023 Filed Sep 21, 2023 17:01 UTC |
Panagos ConstantinosSee Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 11,202 | $0.00 Strike: $161.70 | $0.00 |
DisclosureSEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · derivative · entry 10 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,202 shares Expires 2030-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2023 Filed Sep 21, 2023 17:01 UTC |
Panagos ConstantinosSee Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 7,681 | $0.00 Strike: $131.82 | $0.00 |
DisclosureSEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · derivative · entry 9 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,681 shares Expires 2029-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2023 Filed Sep 21, 2023 17:01 UTC |
Panagos ConstantinosSee Remarks
|
Exercise / conversionStock Appreciation Right · Derivative | 2,853 | $0.00 Strike: $95.23 | $0.00 |
DisclosureSEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · derivative · entry 8 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,853 shares Expires 2028-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2023 Filed Sep 21, 2023 17:01 UTC |
Panagos ConstantinosSee Remarks
|
Disposition to issuerCommon Stock | 18,767 | $208.56 | $3,914,045.52 |
DisclosureSEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · nonDerivative · entry 7 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,250 Read SEC document |
| September 19, 2023 Filed Sep 21, 2023 17:01 UTC |
Panagos ConstantinosSee Remarks
|
SaleCommon Stock | 7,419 | $208.63 | $1,547,825.97 |
DisclosureSEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · nonDerivative · entry 6 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,017 F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $207.71 to $210.12 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 19, 2023 Filed Sep 21, 2023 17:01 UTC |
Panagos ConstantinosSee Remarks
|
Exercise / conversionCommon Stock | 4,450 | $183.82 | $817,999.00 |
DisclosureSEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · nonDerivative · entry 5 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,436 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2023 Filed Sep 21, 2023 17:01 UTC |
Panagos ConstantinosSee Remarks
|
Exercise / conversionCommon Stock | 11,202 | $161.70 | $1,811,363.40 |
DisclosureSEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · nonDerivative · entry 4 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2023 Filed Sep 21, 2023 17:01 UTC |
Panagos ConstantinosSee Remarks
|
Exercise / conversionCommon Stock | 7,681 | $131.82 | $1,012,509.42 |
DisclosureSEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · nonDerivative · entry 3 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2023 Filed Sep 21, 2023 17:01 UTC |
Panagos ConstantinosSee Remarks
|
Exercise / conversionCommon Stock | 2,853 | $95.23 | $271,691.19 |
DisclosureSEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · nonDerivative · entry 2 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2023 Filed Sep 21, 2023 17:01 UTC |
Panagos ConstantinosSee Remarks
|
SaleCommon Stock | 19,898 | $208.69 | $4,152,513.62 |
DisclosureSEC source: 0001478242-23-000091 · wk-form4_1695330080.xml · nonDerivative · entry 1 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,250 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $207.78 to $210.33 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 21:09 UTC |
Bruehlman Ronald ESee Remarks
|
Tax withholdingCommon Stock | 2,588 | $216.29 | $559,758.52 |
DisclosureSEC source: 0001478242-23-000089 · wk-form4_1691442559.xml · nonDerivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,704 Read SEC document |
| July 28, 2023 Filed Aug 1, 2023 21:00 UTC |
Cherofsky KeriannSee Remarks
|
Tax withholdingCommon Stock | 35 | $226.15 | $7,915.25 |
DisclosureSEC source: 0001478242-23-000087 · wk-form4_1690923611.xml · nonDerivative · entry 1 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 864 Read SEC document |
| July 19, 2023 Filed Feb 8, 2024 22:14 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 133 | $225.46 | $29,986.18 |
DisclosureSEC source: 0001478242-24-000011 · wk-form5_1707430480.xml · derivative · entry 3 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,427 Underlying: Common Stock · 133 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| July 19, 2023 Filed Feb 8, 2024 22:15 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 122 | $225.46 | $27,506.12 |
DisclosureSEC source: 0001478242-24-000012 · wk-form5_1707430544.xml · derivative · entry 3 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 862 Underlying: Common Stock · 122 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| July 19, 2023 Filed Feb 8, 2024 22:13 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 155 | $225.46 | $34,946.30 |
DisclosureSEC source: 0001478242-24-000010 · wk-form5_1707430384.xml · derivative · entry 3 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,136 Underlying: Common Stock · 155 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 21:31 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 5,820 | $201.89 | $1,174,999.80 |
DisclosureSEC source: 0001478242-23-000079 · wk-form4_1686173474.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 0 F1 · ownership.nature: Held by Kevin Knightly Revocable Trust Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.